Advertisement
Inventiva S.A.

Inventiva S.A. (IVA) Stock Overview

Explore Inventiva S.A.’s financial performance, market position, analyst ratings, and future outlook.

IVANASDAQ
HealthcareBiotechnology
$3.97
$0.06(1.53%)
U.S. Market opens in 0h 16m
Advertisement

Inventiva S.A. (IVA)

Meyka AI Score

Z

Key Financials

Market Cap206.4M
P/E Ratio-5.96
EPS (TTM)$-2.13
ROE18.38%
Fundamental Analysis

AI Price Forecasts

1 Month$5.97
3 Months$7.40
1 Year Target$7.39

IVA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Inventiva S.A. (IVA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.96 and a market capitalization of 206.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.53%
5-Day Change
-0.25%
1-Month Change
-26.07%
3-Month Change
-37.77%
6-Month Change
-6.81%
Year-to-Date (YTD) Change
-14.62%
1-Year Change
9.67%
3-Year Change
12.78%
5-Year Change
-73.57%
All-Time (Max) Change
-70.42%

Contact Information

33 3 80 44 75 00
50 rue de Dijon, Daix, NaN, 21121

Company Facts

114 Employees
IPO DateJul 10, 2020
CountryFR
Actively Trading

Frequently Asked Questions